Stock A222040 COSMAX NBT, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Cosmax Nbt, Inc.

Equities

A222040

KR7222040008

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-06-27 EDT 		5-day change 1st Jan Change
3,920 KRW +0.26% Intraday chart for Cosmax Nbt, Inc. +3.84% -38.94%
2023 Tranche Update on Cosmax Nbt, Inc.'s Equity Buyback Plan announced on June 27, 2023. CI
2023 Tranche Update on Cosmax Nbt, Inc.'s Equity Buyback Plan announced on June 27, 2023. CI

Strengths

  • Its low valuation, with P/E ratio at 5.25 and 3.87 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • The stock, which is currently worth 2024 to 216.62 times its sales, is clearly overvalued in comparison with peers.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company does not generate enough profits, which is an alarming weak point.
  • The group shows a rather high level of debt in proportion to its EBITDA.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Food Processing

1st Jan change Capi. Investor Rating ESG Refinitiv
COSMAX NBT, INC. Stock Cosmax Nbt, Inc.
-38.94% 58.47M -
ZHEJIANG NHU COMPANY LTD. Stock Zhejiang NHU Company Ltd.
+13.21% 8.12B
D+
BELLRING BRANDS, INC. Stock BellRing Brands, Inc.
+3.08% 7.45B
C-
CSPC INNOVATION PHARMACEUTICAL CO., LTD. Stock CSPC Innovation Pharmaceutical Co., Ltd.
-17.32% 4.88B -
THE SIMPLY GOOD FOODS COMPANY Stock The Simply Good Foods Company
-8.76% 3.62B
B-
BYHEALTH CO., LTD Stock Byhealth Co., Ltd
-20.43% 3.17B
D
XIAMEN KINGDOMWAY GROUP COMPANY Stock Xiamen Kingdomway Group Company
-11.51% 1.21B - -
JAMIESON WELLNESS INC. Stock Jamieson Wellness Inc.
-8.57% 879M
C+
USANA HEALTH SCIENCES, INC. Stock USANA Health Sciences, Inc.
-15.60% 862M
C+
SIRIO PHARMA CO., LTD. Stock Sirio Pharma Co., Ltd.
-5.48% 812M -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
  1. Stock Market
  2. Equities
  3. A222040 Stock
  4. Ratings Cosmax Nbt, Inc.